Australian Clinical Labs Ltd
ASX:ACL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Australian Clinical Labs Ltd
ASX:ACL
|
AU |
|
N
|
Ningbo Orient Wires & Cables Co Ltd
SSE:603606
|
CN |
|
A
|
Ameriwest Lithium Inc
CNSX:AWLI
|
CA |
Australian Clinical Labs Ltd
Australian Clinical Labs Ltd. provides pathology services. The company is headquartered in Melbourne, Victoria and currently employs 2,794 full-time employees. The company went IPO on 2021-05-14. The firm is engaged in private hospital pathology businesses in regions of Western Australia, Victoria, South Australia and the Northern Territory. Its brands include Australian Clinical Labs, SunDoctors, Helix Pathology, Southern Sun, BeFunctional Labs and Gribbles Veterinary Pathology. The Australian Clinical Labs provides pathology in Australia, servicing clinicians, patients, hospitals, commercial clients and public organizations. The SunDoctors offers diagnosis and treatment of skin cancer. The Helix Pathology delivers specialized histopathology and cytology testing services. The Southern Sun is the skin cancer lab and the commercial lab in Australia. The BeFunctional Labs assists practitioners in the diagnosis, treatment and management of patients by providing functional pathology tests. The Gribbles Veterinary Pathology provides animal health professionals with pathology service.
Australian Clinical Labs Ltd. provides pathology services. The company is headquartered in Melbourne, Victoria and currently employs 2,794 full-time employees. The company went IPO on 2021-05-14. The firm is engaged in private hospital pathology businesses in regions of Western Australia, Victoria, South Australia and the Northern Territory. Its brands include Australian Clinical Labs, SunDoctors, Helix Pathology, Southern Sun, BeFunctional Labs and Gribbles Veterinary Pathology. The Australian Clinical Labs provides pathology in Australia, servicing clinicians, patients, hospitals, commercial clients and public organizations. The SunDoctors offers diagnosis and treatment of skin cancer. The Helix Pathology delivers specialized histopathology and cytology testing services. The Southern Sun is the skin cancer lab and the commercial lab in Australia. The BeFunctional Labs assists practitioners in the diagnosis, treatment and management of patients by providing functional pathology tests. The Gribbles Veterinary Pathology provides animal health professionals with pathology service.
Profitability & Margins: ACL delivered improved underlying profitability, with EBIT up 2.4% to $28 million and margin expanding by 30 basis points to 7.7%, despite a 1% decline in revenue.
EPS Growth: Underlying earnings per share rose 12.8% to $0.067, helped by higher profits and the share buyback program.
Revenue Guidance: Revenue guidance for FY26 was updated to reflect a subdued H1 and modest expected growth in H2, incorporating early data from January and February.
Cash Returns: The company returned $27.8 million to shareholders via dividends and buybacks, and declared an interim dividend of $0.0375 per share, up $0.0025 from H1 2025.
Operational Improvements: Efficiency and technology investments (AI, automation, digital billing) drove cost control, with labor as a percentage of revenue under 44% and significant improvements in logistics and collections.
Cost Pressures: Wage inflation and pending Fair Work Commission rulings on pay rates create future cost headwinds, but management is pursuing mitigation strategies and lobbying for government support.
CEO Transition: CEO Melinda McGrath announced her resignation effective August 30, 2026.
